← Back to Patent Explorer
US5376529A Expired / Lapsed US ⏱️ 0.0 years remaining

Lactam-containing compositions and methods useful for the hybridization of nucleic acids

Assignee: Becton Dickinson and Co
•
Filing: 1991-12-13
•
Granted: 1994-12-27
•
Expires: 2011-12-13
📄 Original PDF 🌐 Google Patents 🔄 Sync Now

Abstract

Abstract This invention relates to novel methods for the release of nucleic acids from cells in complex biological samples or specimens to prepare and make available the nucleic acid material present for a hybridization assay or for extraction. Novel methods for hybridization of nucleic acids are also presented. In particular methods are described for isolating nucleic acid from a sample containing a complex biological mixture of nucleic acid and non-nucleic acids wherein the sample is combined with a hybridization medium comprising a lactam which promotes and enables nucleic acid pairing when complementary nucleic acid is introduced. The lactam is preferably about 5 to about 70% of the hybridization medium and is most preferably 2-pyrrolidone, N-ethyl-2-pyrrolidone, N-cyclohexyl-2-pyrrolidone, N-dodecyl-2-pyrrolidone, N-methyl-2-pyrrolidone, N-hydroxyethyl-2-pyrrolidone, N-methyl-2-piperidone, 2-ε-caprolactam, N-methyl-2-caprolactam, 2-piperidone or N-(4-hydroxybenzyl)pyrrolidone.

Inventors

  • 👤 Jeffrey Van Ness
  • 👤 Nicolaas M. J. Vermeulen

Bibliographic Details

Application Number —
Jurisdiction US
Data Source google_patents
Last Synchronized 2026-11-09 22:03
CPC Classifications
C; C12; C12Q; C12Q1/00; C12Q1/68; C12Q1/6813; C12Q1/6832; C12Q1/6876

Claims Analysis

Total Claims: 7
Claim 1
Independent Claim 50 words
A composition for simultaneously lysing cells and hybridizing released endogenous nucleic acid, comprising: a buffer solution; at least one monomeric lactam at a concentration of about 5% to about 70% of the total volume of the buffer solution; and a detergent at a concentration of about 0.05% to about 0.5%.
Claim 2
Dependent Claim 50 words
A composition for simultaneously lysing cells and hybridizing released endogenous nucleic acid, comprising: a buffer solution; at least one monomeric lactam at a concentration of about 5% to about 70% of the total volume of the buffer solution; and a detergent at a concentration of about 0.05% to about 0.5%.
Claim 3
Dependent Claim 10 words
The composition of claim 1 further comprising a chaotropic agent.
Claim 4
Dependent Claim 14 words
The composition of claim 1 further comprising about 1 to about 10 mM EDTA.
Claim 5
Dependent Claim 11 words
The composition of claim 1 further comprising a volume exclusion agent.
Claim 6
Dependent Claim 58 words
A kit for simultaneously lysing cells and hybridizing released endogenous nucleic acid, comprising at least one vial containing a composition comprising: a buffer solution; at least one monomeric lactam at a concentration of about 5% to about 70% of the total volume of the buffer solution; and a detergent at a concentration of about 0.05% to about 0.5%.
Claim 7
Dependent Claim 58 words
A kit for simultaneously lysing cells and hybridizing released endogenous nucleic acid, comprising at least one vial containing a composition comprising: a buffer solution; at least one monomeric lactam at a concentration of about 5% to about 70% of the total volume of the buffer solution; and a detergent at a concentration of about 0.05% to about 0.5%.

References Cited (Backward Citations)

US4302204A Cited
US4830969A Cited
US4483920A Cited
US4652517A Cited

USPTO Annuity & Maintenance Windows

Annuity Stage Window Opens Payment Deadline Surcharge Period Until Estimated Fee Status
3.5 Years (Year 4) 1997-12-26 1998-06-27 1998-12-27 $2000.00 Window Closed / Lapsed
7.5 Years (Year 8) 2001-12-26 2002-06-27 2002-12-27 $3760.00 Window Closed / Lapsed
11.5 Years (Year 12) 2005-12-26 2006-06-27 2006-12-27 $7700.00 Window Closed / Lapsed

Assigned Categories & Tags

No categories assigned to this patent yet.

Assign Category Tag